Immunovant (IMVT) Change in Cash (2019 - 2026)
Immunovant (IMVT) posted Change in Cash of -$92.4 million for Q1 2026, down 119.55% on a QoQ basis from $472.7 million in Q4 2025, and down 127.24% year-over-year from $339.3 million in Q1 2025.
Immunovant (IMVT) Change in Cash (2019 - 2026) Analysis & Trends
Immunovant's Change in Cash history runs 8 years deep, the most recent figure standing at -$92.4 million for Q1 2026.
- Quarterly Change in Cash fell 127.24% year-over-year to -$92.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $188.1 million (up 139.34% YoY) and the FY2026 annual result came in at $188.1 million, up 139.34% from the prior year.
- Change in Cash was -$92.4 million for Q1 2026 at Immunovant, down from $472.7 million in the prior quarter.
- Across five years, Change in Cash topped out at $472.7 million in Q4 2025 and bottomed at -$115.1 million in Q2 2025.
- A 5-year average of $22.1 million and a median of -$56.1 million in 2023 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2022 — Change in Cash tumbled 215.08% — and 2023, when it jumped 1468.88%.
- Immunovant's Change in Cash stood at $26.8 million in 2022, then soared by 1468.88% to $421.0 million in 2023, then plunged by 123.34% to -$98.3 million in 2024, then soared by 581.04% to $472.7 million in 2025, then tumbled by 119.55% to -$92.4 million in 2026.
- Business Quant data shows IMVT's Change in Cash at -$92.4 million in Q1 2026, $472.7 million in Q4 2025, and -$77.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 243.78 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Immunovant | 7.18 Bn | 7.18 Bn | - | -92.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -92.42 Mn |
| Dec 31, 2025 | 472.66 Mn |
| Sep 30, 2025 | -77.04 Mn |
| Jun 30, 2025 | -115.06 Mn |
| Mar 31, 2025 | 339.29 Mn |
| Dec 31, 2024 | -98.26 Mn |
| Sep 30, 2024 | -87.06 Mn |
| Jun 30, 2024 | -75.36 Mn |
| Mar 31, 2024 | -55.57 Mn |
| Dec 31, 2023 | 421.01 Mn |
| Sep 30, 2023 | -60.03 Mn |
| Jun 30, 2023 | -46.57 Mn |
| Mar 31, 2023 | -56.08 Mn |
| Dec 31, 2022 | 26.84 Mn |
| Sep 30, 2022 | -21.43 Mn |
| Jun 30, 2022 | -66.61 Mn |
| Mar 31, 2022 | -33.19 Mn |
| Dec 31, 2021 | -31.95 Mn |
| Sep 30, 2021 | 179.95 Mn |
| Jun 30, 2021 | -21.14 Mn |